Varian Manufactures Halcyon Radiotherapy Systems in Germany for the First Time

Siemens HealthineersVarian, a Siemens Healthineers company, manufactures the first Halcyon radiotherapy system at its Kemnath site. Siemens Healthineers built a completely new production line at the plant and expanded its research and development team. With the acquisition of Varian, these are once again part of the Siemens Healthineers product portfolio. Systems for the German, European and US markets are manufactured in Kemnath. The first Halcyon from Kemnath goes to Curavid Radiotherapy and Radiology in Lübeck. Siemens Healthineers announced in February 2022 that it would invest EUR 60 million in the Kemnath production site and create 50 new jobs. The expansion of the production to include radiotherapy devices is part of this investment.

"We want to further expand the production of radiotherapy systems in Kemnath and increase the quantities. We also want to increase the vertical integration of the Halcyon system by producing more individual parts here in the plant," said Michael Braunreuther, head of the Kemnath site at Siemens Healthineers. "The expansion of our portfolio here in Kemnath is a further commitment to Germany as a location for innovation."

Radiotherapy is one of the most important methods of modern cancer therapy and is now used in more than half of all cancer treatments. The radiotherapy devices, so-called linear accelerators, are part of the product portfolio of Varian, now a Siemens Healthineers company. Linear accelerators are used both in the outpatient sector and in hospitals for the targeted treatment of cancer. The Halcyon system from Varian is one of the most technically innovative accelerator systems on the market. Siemens Healthineers built another production site for these systems in Kemnath. A second production site is located in Beijing. Until 2012, Siemens Healthineers manufactured radiotherapy systems in Kemnath. Parts of the infrastructure, such as the radiation-proof test cabins, are still available and can be used to test the new Varian systems. The production of radiotherapy systems complements the existing portfolio at the site. The Kemnath plant in the Oberpfalz region was established in 1962. It has grown since then from a purely contract-based manufacturer to a Center of Competence for mechatronics that covers large parts of the Siemens Healthineers product range. The components developed and manufactured in Kemnath include C-arms for angiography systems in addition to tables for MRI units and components for analytical systems used in lab diagnostics. In the future, tables for the TrueBeam radiotherapy system will also be manufactured here.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...

AI-Supported Breast Cancer Screening - N…

The new findings are published in The Lancet Digital Health. The initial results of the Mammography Screening with Artificial Intelligence (MASAI) study* - a randomised trial to evaluate whether AI...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Improves Personalized Cancer Treatmen…

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these...

The Future of Healthcare is Digital

8 - 10 April 2025, Berlin, Germany. The Berlin Exhibition Centre will be all about digital health from 8 to 10 April 2025. DMEA, Europe's leading event for digital healthcare, organised...

DMEA nova Award: Looking for the Best Id…

8 - 10 April 2025, Berlin, Germany. Innovative startups from the digital health sector can now apply for the DMEA nova Award 2025. We are looking for the best idea or...

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

AI Accelerates the Search for New Tuberc…

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Students Around the World Find ChatGPT U…

An international survey study involving more than 23,000 higher education students reveals trends in how they use and experience ChatGPT, highlighting both positive perceptions and awareness of the AI chatbot’s...